Blood pressure medication improves COVID-19 survival rates,
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Medication for high blood pressure could improve Covid-19 survival rates and reduce the severity of infection - according to new research from the University of East Anglia.

Researchers studied 28,000 patients taking antihypertensives. They found that the risk of severe Covid-19 illness and death was reduced for patients with high blood pressure who were taking Angiotensin-Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARB).

The team analysed data from 19 studies related to Covid-19 and ACEi and ARB medications. The meta-analysis involved more than 28,000 patients and is the largest and most detailed such study to date.

They compared data from Covid-19 patients who were taking ACEi or ARB medications with those who were not - focusing on whether they experienced 'critical' events and death.

They found that a third of Covid-19 patients with high blood pressure and a quarter of patients overall were taking an ACEi/ARBs. This is likely due to the increasing risk of infection in patients with co-morbidities such as cardiovascular diseases, hypertension and diabetes.

"But the really important thing that we showed was that there is no evidence that these medications might increase the severity of Covid-19 or risk of death, On the contrary, we found that there was a significantly lower risk of death and critical outcomes, so they might in fact have a protective role - particularly in patients with hypertension", said researchers.

Covid-19 patients with high blood pressure who were taking ACEi/ARB medications were 0.67 times less likely to have a critical or fatal outcome than those not taking these medications. This research provides substantial evidence to recommend continued use of these medications if the patients were taking them already.

Source: https://pxmd.co/bjogO
Dr. T●●●●z H●●●●●●i and 5 others like this7 shares
Like
Comment
Share
Dr. R●●●●h  b●●u
Dr. R●●●●h b●●u General Medicine
Good news for hypertensives.
Aug 24, 2020Like
Dr. J●●l L●●●●●●●●●a
Dr. J●●l L●●●●●●●●●a General Management
Very informative 👍
Aug 24, 2020Like